Zusammenfassung
In dieser Übersicht werden die nichtrhythmogene und nichtvalvuläre Form der Herzinsuffizienz besprochen, also die Myokardinsuffizienz im engeren Sinne. Neben der Bestimmung der natriuretischen Peptide ist die Echokardiographie eine wichtige diagnostische Methode, mit deren Hilfe Myokardinsuffizienzen mit erhaltener systolischer Funktion (HF-PEF) und mit relevant reduzierter linksventrikulärer systolischer Funktion (HF-REF) unterschieden werden können. Während der Erstdiagnostik besteht außerdem häufig die Indikation zur Herzkatheteruntersuchung. Als leicht durchführbarer Funktionstest hat sich der 6-min-Gehtest bewährt. Die Spiroergometrie kann anhand der vielen erhobenen Messparameter weitere, für die differenzialdiagnostische und prognostische Einschätzung wichtige Informationen liefern.
Abstract
In this review, heart failure is confined to etiologies not due to rhythm disturbances or valvular heart disease. Besides measurement of natriuretic peptides, echocardiography is established as an important diagnostic procedure. Echocardiography is especially helpful in discriminating between heart failure with preserved ejection fraction (HF-PEF) and reduced ejection fraction (HF-REF). Because of its ease to be performed, the 6 min walk test continues to be a standard diagnostic procedure. Cardiopulmonary exercise testing provides more detailed information regarding differential diagnostic and prognostic considerations.
Literatur
Achenbach S, Barkhausen J, Beer M et al (2012) Consensus recommendations of the German Radiology Society (DRG), the German Cardiac Society (DGK) and the German Society for Pediatric Cardiology (DGPK) on the use of cardiac imaging with computed tomography and magnetic resonance imaging. Rofo 184:345–368
Adams KF Jr, Fonarow GC, Emerman CL et al (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149:209–216
Agarwal SK, Simpson RJ Jr, Rautaharju P et al (2012) Relation of ventricular premature complexes to heart failure (from the Atherosclerosis Risk In Communities [ARIC] Study). Am J Cardiol 109:105–109
American College of Cardiology Foundation Task Force on Expert Consensus, Hundley WG, Bluemke DA et al (2010) ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 55:2614–2662
Arena R, Myers J, Abella J et al (2007) Development of a ventilatory classification system in patients with heart failure. Circulation 115:2410–2417
Caforio AL, Pankuweit S, Arbustini E et al (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34:2636–2648, 2648a–2648d
Cahalin LP, Mathier MA, Semigran MJ et al (1996) The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 110:325–332
Chen T, Koene R, Benditt DG et al (2013) Ventricular ectopy in patients with left ventricular dysfunction: should it be treated? J Card Fail 19:40–49
Cruz DN, Schmidt-Ott KM, Vescovo G et al (2013) Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 182:117–136
De Bruyne B, Pijls NH, Kalesan B et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991–1001
Ho KK, Anderson KM, Kannel WB et al (1993) Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88:107–115
Hobbs FD, Roalfe AK, Davis RC et al (2007) Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J 28:1128–1134
Khan NK, Goode KM, Cleland JG et al (2007) Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge. Eur J Heart Fail 9:491–501
Khayat R, Small R, Rathman L et al (2013) Sleep-disordered breathing in heart failure: identifying and treating an important but often unrecognized comorbidity in heart failure patients. J Card Fail 19:431–444
Maisel A, Mueller C, Adams K Jr et al (2008) State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 10:824–839
Maisel WH, Stevenson LW (2003) Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 91:2D–8D
McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847
McMurray JJ, Stewart S (2000) Epidemiology, aetiology, and prognosis of heart failure. Heart 83:596–602
Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10:165–193
Newby LK, Jesse RL, Babb JD et al (2012) ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol 60:2427–2463
Nieminen MS, Brutsaert D, Dickstein K et al (2006) EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27:2725–2736
Pardaens S, Calders P, Derom E et al (2013) Exercise intolerance in heart failure: update on exercise parameters for diagnosis, prognosis and therapeutic interventions. Acta Cardiol 68:495–504
Redfield MM, Jacobsen SJ, Burnett JC Jr et al (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289:194–202
Romero SP, Garcia-Egido A, Escobar MA et al (2013) Impact of new-onset diabetes mellitus and glycemic control on the prognosis of heart failure patients: a propensity-matched study in the community. Int J Cardiol 167:1206–1216
Ronco C, Cicoira M, McCullough PA (2012) Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol 60:1031–1042
Senior R, Becher H, Monaghan M et al (2009) Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography. Eur J Echocardiogr 10:194–212
Einhaltung ethischer Richtlinien
Interessenkonflikt. A. Hummel, K. Empen, M. Dörr und S.B. Felix geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hummel, A., Empen, K., Dörr, M. et al. Diagnostik der systolischen und diastolischen Herzinsuffizienz. Internist 55, 647–654 (2014). https://doi.org/10.1007/s00108-013-3425-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00108-013-3425-2